Repro-Med Announces Freedom60(R) Agreement With Chartwell Pennsylvania
05 Juin 2006 - 6:51PM
PR Newswire (US)
CHESTER, N.Y., June 5 /PRNewswire-FirstCall/ -- Repro-Med Systems,
Inc. (OTC:REPR.OB) (BULLETIN BOARD: REPR.OB) , the leading
developer and manufacturer of portable medical devices for infusion
therapy and respiratory products, today announced a Freedom60(R)
supply agreement with Chartwell Pennsylvania, L.P., a provider of
home infusion and enteral nutrition therapy services along with
clinical monitoring, dietary consultation, infusion nursing, pump
management and delivery services. "We understand how important it
is for Chartwell to maximize the quality of life and dignity of the
patients and clients they serve. We're pleased that Chartwell has
the confidence that the Freedom60(R) will enhance their clients'
experience and are confident that Chartwell and their patients will
enjoy the precision and independence provided by the Freedom60(R),"
said Andy Sealfon, President of Repro-Med. "Chartwell is committed
to providing high quality infusion therapy services, ensuring safe,
quality, and cost-effective infusion therapy at home. We believe
that Repro-Med's Freedom60(R) will contribute to our provision of
the highest level of patient treatment outcomes in a low-cost,
patient-preferred home setting," stated Lynn Giglione RN BSN,
Chartwell's General Manager. About Chartwell Chartwell provides a
complete constellation of clinical, administrative, and care
coordination services provided by home infusion pharmacy
organizations. Chartwell is committed to caring for patients with a
wide range of diagnoses and home infusion therapy needs, providing
a clinically safe and effective alternative to hospitalization.
Chartwell employs more than 100 highly skilled clinical and
supportive professionals including nurses, pharmacists,
reimbursement experts and customer service specialists who are
committed to providing the highest level of service possible to
patients. Working in partnership with local physicians, hospitals
and nursing agencies, the clinical staff is dedicated to making
sure each patient experiences a positive, successful therapy
outcome in the comfort of their own home. About Repro-Med Repro-Med
Systems, Inc. engages in the design and manufacture of hand powered
portable medical devices for emergency respiratory applications and
infusion therapy worldwide. Repro-Med manufactures medical devices
for a variety of markets including hospital, emergency-care and
home-care. The Company's primary products are Freedom60(R) and
Res-Q-Vac(TM). The Freedom60(R) Syringe Infusion Pump provides a
portable, high quality, self powered, maintenance free delivery
system for home, ambulatory and hospital use. The patented
mechanical variable rate flow control device delivers precise
infusion rates and uniform flow profiles that provide consistent
transfer of medication. The Freedom60(R) is a versatile,
easy-to-use lightweight mechanical pump providing a cost-effective
alternative to expensive electronic and disposable IV
administration devices used to deliver a wide range of infusion
products including antibiotics, pain control, chemotherapy drugs,
immune globulin, desferal and cardiac drugs. Res-Q-Vac(TM) is
currently the market leader in providing a portable hand powered
suction system designed to remove fluids from a patient's airway.
The Res-Q-Vac(TM) patented Full Stop Protection Filter(TM) and
disposable design eliminate the risk of contaminating the health
care provider when suctioning a patient or during post treatment
cleanup. The product is ideally suited for hospitals and emergency
providers for primary suction needs or as backup support for
powered suction systems. Forward Looking Statements Statements in
this press release may contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements, other than statements of historical facts,
may be forward-looking statements. These statements are based on
management's current expectations and are subject to uncertainty
and changes in circumstances. These statements involve risks and
uncertainties that could cause actual results to differ materially
from those included in forward-looking statements due to a variety
of factors. More information about these factors can be found in
Repro-Med's latest Annual Report filed with Securities and Exchange
Commission on Form 10-KSB. The company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
Contact: Repro-Med, Inc. Andrew Sealfon, 800.624.9600 DATASOURCE:
Repro-Med Systems, Inc. CONTACT: Andrew Sealfon of Repro-Med, Inc.,
1-800-624-9600 Web site: http://www.repro-med.com/
Copyright